Intestinal and hepatic drug transporters: pharmacokinetic, pathophysiological, and pharmacogenetic roles

被引:0
|
作者
Tomohiro Terada
Daiki Hira
机构
[1] Shiga University of Medical Science Hospital,Department of Pharmacy
来源
关键词
Drug transporters; Pharmacokinetics; Polymorphisms; Drug–drug interaction;
D O I
暂无
中图分类号
学科分类号
摘要
The efficacy and safety of pharmacotherapies are determined by the complex processes involved in the interactions between drugs with the human body, including pharmacokinetic aspects. Among pharmacokinetic factors, it has been recognized that drug transporters play critical roles for absorption, distribution and excretion of drugs, regulating the membrane transport of drugs. The vast amounts of information on drug transporters collected in the past 20 years have been organized according to biochemical, molecular, genetic, and clinical analyses. Novel technologies, public databases, and regulatory guidelines have advanced the use of such information in drug development and clinical practice. In this review, we selected some clinically important drug transporters expressed in the intestine and liver, and introduced the research history and current knowledge of their pharmacokinetic, pathophysiological, and pharmacogenetic implications.
引用
收藏
页码:508 / 519
页数:11
相关论文
共 50 条
  • [21] Intestinal efflux transporters and drug absorption
    Murakami, Teruo
    Takano, Mikihisa
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (07) : 923 - 939
  • [22] Defining drug disposition determinants: a pharmacogenetic-pharmacokinetic strategy
    Katz, David A.
    Murray, Bernard
    Bhathena, Anahita
    Sahelijo, Leonardo
    NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (04) : 293 - 305
  • [23] Pharmacogenetic Screening for Polymorphisms in Drug-Metabolizing Enzymes and Drug Transporters in a Dutch Population
    T. M. Bosch
    V. D. Doodeman
    P. H. M. Smits
    I Meijerman
    J. H. M. Schellens
    J. H. Beijnen
    Molecular Diagnosis & Therapy, 2006, 10 : 175 - 185
  • [24] Pharmacogenetic screening for polymorphisms in drug-metabolizing enzymes and drug transporters in a dutch population
    Bosch, T. M.
    Doodeman, V. D.
    SmitS, P. H. M.
    Meijerman, I.
    Schellens, J. H. M.
    Beijnen, J. H.
    MOLECULAR DIAGNOSIS & THERAPY, 2006, 10 (03) : 175 - 185
  • [25] EFFECTS OF ANTIOXIDANTS IN DRUG PRODUCTS ON INTESTINAL DRUG TRANSPORTERS
    Koleske, M.
    Kulkarni, C.
    Alam, K.
    Raw, A.
    Rege, B.
    Zhao, L.
    Lu, D.
    Zhang, L.
    Giacomini, K.
    Kroetz, D.
    Yee, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S85 - S85
  • [26] Pharmacokinetic problems in clinical practice - role of drug transporters
    Rosskopf, D.
    Kroemer, H. K.
    Siegmund, W.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2009, 134 (08) : 345 - 356
  • [27] DRUG TRANSPORTERS: STARRING ROLES IN NEW DRUG DISCOVERY AND DEVELOPMENT
    Sugiyama, Yuichi
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S4 - S5
  • [28] Segmental intestinal transporters and metabolic enzymes on intestinal drug absorption
    Tam, D
    Tirona, RG
    Pang, KS
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (04) : 373 - 383
  • [29] Pathophysiological Roles of Ductular Reaction in Liver Inflammation and Hepatic Fibrogenesis
    Sato, Keisaku
    Pham, Linh
    Glaser, Shannon
    Francis, Heather
    Alpini, Gianfranco
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2023, 15 (03): : 803 - 805
  • [30] THE ROLE OF HEPATIC TRANSPORTERS IN DRUG DISPOSITION AND ELIMINATION
    Brouwer, Kim L. R.
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S2 - S2